A new study shows that a single dose of CBD may reduce alcohol cravings, offering the first clinical evidence that it could ...

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects ...

Study: Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive ...

For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxie ...

The findings of this randomized clinical trial show that cannabidiol (CBD) can be used safely in women with advanced breast cancer and clinical anxiety. Although the study did not meet its primary end ...

Cannabidiol (CBD) had no effect on scan-related anxiety (scanxiety), but it significantly eased overall anxiety in women with ...

Primary endpoint was not met, but CBD was safe and demonstrated significantly lower anxiety levels. (HealthDay News) — For patients with advanced breast cancer and baseline clinical anxiety ...

This study seeks people age 18 or older with ASD and who have a significant mood disorder or other behaviors that interfere with function and quality of life ...

UK food regulators have lowered the recommended safe daily dose of cannabidiol (CBD), a cannabis extract present in many different High Street products, including drinks and snacks. The Food ...

Cannabidiol 1 is a small molecule commercialized by Cardiol Therapeutics, with a leading Phase II program in Pericarditis.

Cannabidiol Market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a CAGR of 16.3% from 2024 to 2031 Mr. Shah Coherent Market Insights Pvt.